Newsletter

Long-term Beta-blocker Treatment in Acute Myocardial Infarction: Are the Benefits Questionable?

[메디칼업저버 박선혜 기자] Beta-blockers have been successful as a treatment for acute myocardial infarction. Patients with acute myocardial infarction with preserved left ventricular ejection fraction of 50% or more did not significantly reduce the risk of death from any cause or new myocardial infarction, even if they took beta-blockers for an extended period of time. […]

Jardiance’s Impact on Heart Failure Risk in Acute Myocardial Infarction Patients

[메디칼업저버 양영구 기자] Boehringer Ingelheim’s SGLT-2 inhibitor Jardiance (ingredient name: empagliflozin) was found to have no positive effect on reducing the risk of heart failure in patients with acute myocardial infarction. Jardiance has gone mainstream by improving cardiovascular disease risk in patients with heart failure, type 2 diabetes at high risk for cardiovascular disease, and […]

Former Chinese Prime Minister Li Keqiang Passes Away Unexpectedly at Age 68

Former Chinese Leader Li Keqiang Dies Suddenly of a Heart Attack BEIJING, October 27 – Former Chinese leader Li Keqiang, aged 68, passed away yesterday from a sudden heart attack or acute myocardial infarction, as confirmed by Chinese media outlet CCTV. The news of his untimely demise sent shockwaves through the nation. Heart Attack Strikes […]

International Experts Unveil Initiative to Reduce Global Burden of Sudden Cardiac Death

On September 16, 2023, it was reported that millions of people worldwide die from sudden cardiac death each year, with a survival rate of less than 10%. However, under certain circumstances, the survival rate can reach 80%. Approximately half of those who experience sudden cardiac death have their first manifestation of cardiovascular disease. To address […]